This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies. Click here for more information on cookies and to set your preferences.

Integrity in our business practices

To maintain trust in our relationships with company stakeholders—patients, customers, shareholders, suppliers and other business partners, and members of the civil society—in which Sanofi operates

Fighting bribery  & corruption
Fighting bribery & corruption
At Sanofi, fighting all forms of corruption is a priority.
Fighting bribery  & corruption

Corruption deters economic development, as it can undermine fair competition and destroy trust in a company or individual. At Sanofi, fighting all forms of corruption is a priority. Promoting a culture of ethics and integrity is key to maintaining the trust of patients, stakeholders and society. Sanofi is committed to fostering a culture of integrity throughout the organization and clearly communicating expectations to reduce the risk of corruption.

Sanofi employees are prohibited from giving, promising to give or offering to give anything of value, to any person for the purpose of influencing any act or decision, notably when interacting with Healthcare Professionals (HCPs) and government officials.

This prohibition also applies to indirect corruption, that is, acts carried out by a third party in the name or on behalf of Sanofi.

Anything of value may include but is not limited to:

  • cash
  • gifts
  • entertainment, accommodations and meals
  • travel expenses
  • services
  • employment offers
  • loans
  • donations or contributions
  • any transfer of value, even of nominal value.

In light of international treaties and laws, companies involved in corruption may face serious reputational damages and be liable for heavy civil and criminal fines. They may also face significant adverse commercial consequences (e.g. loss of contracts).

In addition to putting companies at risk, corrupt employees may also be personally liable for civil and criminal penalties, including heavy fines and prison sentences.

Given the extraterritorial application of some anti-corruption regulations, corrupt practices committed in one country may result in sanctions in multiple countries, further exposing violators to penalties.

In order to promote a culture of ethics and integrity, as well as, to comply with all applicable anti-corruption anti-bribery laws and regulations, Sanofi has implemented a comprehensive set of policies and standards defining clear rules that must be complied with by all Sanofi employees and, when applicable, by third parties.

These policies and standards govern certain activities to ensure they are implemented for genuine and legitimate business reasons and include specific provisions aiming at preventing bribery and corruption.

Sanofi prohibits Facilitating Payments, even when legally permitted.

These policies and standards are not meant to be exhaustive in addressing all the circumstances that may arise. If a particular situation is not covered or the provisions of the policies and standards are not clear to a Sanofi employee, the latter must consult his or her manager and/or the Legal and Ethics & Business Integrity Department.